Publication Cover
Redox Report
Communications in Free Radical Research
Volume 12, 2007 - Issue 5
336
Views
23
CrossRef citations to date
0
Altmetric
Research Articles

Quantitative determination of ortho- and meta-tyrosine as biomarkers of protein oxidative damage in β-thalassemia

, , , , , , & show all
Pages 219-228 | Published online: 19 Jul 2013

REFERENCES

  • Halliwell B, Gutteridge JMC. Free Radicals in Biology and Medicine, 3rd edn. London: Oxford University Press, 1999.
  • Naithani R, Chandra J, Bhattacharjee J, Verma P. Narayan S. Peroxidative stress and antioxidant enzymes in children with beta-thalassemia major. Pediatr Blood Cancer 2006; 46: 780–785.
  • Kassab-Chekir A, Laradi S, Ferchichi S et al. Oxidant, antioxidant status and metabolic data in patients with beta-thalassemia. Clin Chim Ada 2003; 338: 79–86.
  • Halliwell B, Gutteridge JM. Oxygen toxicity, oxygen radicals, transition metals and disease. Biochem J1984; 219: 1-14.
  • Stadtman ER. Protein oxidation and aging. Science 1992; 257: 1220–1224.
  • Dean RT, Fu S, Stocker R, Davies MJ. Biochemistry and pathology of radical-mediated protein oxidation. Biochem J 1997; 324: 1–18.
  • Hahalis G, Alexopoulos D, Kremastinos DT, Zoumbos NC. Heart failure in beta-thalassemia syndromes: a decade of progress. Am J Med 2005; 118: 957–967.
  • Meral A, Tuncel P, Surmen-Gur E, Ozbek R, Ozturk E, Gunay U. Lipid peroxidation and antioxidant status in beta-thalassemia. Pediatr Hematol Oncol 2000; 17: 687–693.
  • Livrea MA, Tesoriere L, Pintaudi AM et al. Oxidative stress and antioxidant status in beta-thalassemia major: iron overload and depletion of lipid-soluble antioxidants. Blood 1996; 88: 3608–3614.
  • Domenica Cappellini M, Tavazzi D, Duca L, Marelli S, Fiorelli G. Non-transferrin-bound iron, iron-related oxidative stress and lipid peroxidation in beta-thalassemia intermedia. Transfus Sci 2000; 23: 245–246.
  • Walter PB, Fung EB, Killilea DW et al. Oxidative stress and inflammation in iron-overloaded patients with beta-thalassaemia or sickle cell disease. Br J Haematol 2006; 135: 254–263.
  • Davies MJ. The oxidative environment and protein damage. Biochim Biophys Acta 2005; 1703: 93–109.
  • Ishimitsu S, Fujimoto S, Ohara A. Determination of m-tyrosine and o-tyrosine in human serum by high-performance liquid chromatography with fluorimetric detection. J Chromatogr 1986; 378: 222–225.
  • Kaur H, Halliwell B. Detection of hydroxyl radicals by aromatic hydroxylation. Methods Enzymol 1994; 233: 67–82.
  • Marquez CD, Weintraub ST, Smith PC. Femtomole detection of amino acids and dipeptides by gas chromatography-negative-ion chemical ionization mass spectrometry following alkylation with pentafluorobenzyl bromide. J Chromatogr B Biomed Appl 1994; 658: 213–221.
  • Duncan MW, Poljak A. Amino acid analysis of peptides and proteins on the femtomole scale by gas chromatography/mass spectrometry. Anal Chem 1998; 70: 890–896.
  • Poljak A, Pamphlett R, Gurney ME, Duncan MW. Measurement of o- and m-tyrosine as markers of oxidative damage in motor neuron disease. Redox Report 2000; 5: 137–140.
  • Davies SM, Poljak A, Duncan MW, Smythe GA, Murphy MP. Measurements of protein carbonyls, ortho- and meta-tyrosine and oxidative phosphorylation complex activity in mitochondria from young and old rats. Free Radic Biol Med 2001; 31: 181–190.
  • Poljak A, Dawes IW, Ingelse BA, Duncan MW, Smythe GA, Grant CM. Oxidative damage to proteins in yeast cells exposed to adaptive levels of H(2)0(2). Redox Report 2003; 8: 371–377.
  • Ghio AJ, Ford ES, Kennedy TP, Hoidal JR. The association between serum ferritin and uric acid in humans. Free Radic Res 2005; 39: 337–342.
  • Gurbak M, Sivasli E, Coskun Y, Bozkurt AT, Ergin A. Prevalence and hematological characteristics of beta-thalassemia trait in Gaziantep urban area, Turkey. Pediatr Hematol Oncol 2006; 23: 419–425.
  • Nielsen F, Mikkelsen BB, Nielsen JB, Andersen HR, Grandjean P. Plasma malondialdehyde as biomarker for oxidative stress: reference interval and effects of life-style factors. Clin Chem 1997; 43: 1209–1214.
  • Garibaldi S, Aragno I, Odetti P, Marinari UM. Relationships between protein carbonyls, retinol and tocopherols level in human plasma. Biochem Mol Biol Int 1994; 34: 729–736.
  • Livrea MA, Tesoriere L, Maggio A, D'Arpa D, Pintaudi AM, Pedone E. Oxidative modification of low-density lipoprotein and atherogenetic risk in beta-thalassemia. Blood 1998; 92: 3936–3942.
  • Fountoulakis M, Lahm H-W. Hydrolysis and amino acid composition analysis of proteins. J Chromatogr A 1998; 826: 109–134.
  • Molnar-Perl I, Pinter-Szakacs M, Khalifa M. High-performance liquid chromatography of tryptophan and other amino acids in hydrochloric acid hydrolysates. J Chromatogr A 1993; 632: 57–61.
  • Tsugita A, Scheffler JJ. A rapid method for acid hydrolysis of protein with a mixture of trifluoroacetic acid and hydrochloric acid. Eur J Biochem 1982; 124: 585–588.
  • Tsugita A, Uchida T, Mewes HW, Ataka T. A rapid vapor-phase acid (hydrochloric acid and trifluoroacetic acid) hydrolysis of peptide and protein. J Biochem (Tokyo) 1987; 102: 1593–1597.
  • Stocks J, Dormandy TL. The autoxidation of human red cell lipids induced by hydrogen peroxide. Br J Haematol 1971; 20: 95–111.
  • Winterbourn CC, Hawkins RE, Brian M, Carrell RW. The estimation of red cell superoxide dismutase activity. J Lab Clin Med 1975; 85: 337–341.
  • Beutler E. A Manual of Biochemical Methods: Glutathione peroxidase, 3rd edn. London: Grune and Stratton, 1984.
  • Beutler E, Duron O, Kelly BM. Improved method for the determination of blood glutathione. J Lab Clin Med 1963; 61: 882–888.
  • Davies MJ, Fu S, Wang H, Dean RT. Stable markers of oxidant damage to proteins and their application in the study of human disease. Free Radic Biol Med 1999; 27: 1151–1163.
  • Levine RL, Garland D, Oliver CN et al. Determination of carbonyl content in oxidatively modified proteins. Methods Enzymol 1990; 186: 464 478.
  • Lee AT, Cerami A. Role of glycation in aging. Ann NY Acad Sci 1992; 663: 63–70.
  • Sensi M, Pricci F, Andreani D, Di Mario U. Advanced nonenzymatic glycation endproducts (AGE): their relevance to ging and the pathogenesis of late diabetic complications. Diabetes Res 1991; 16: 1–9.
  • Shinar E, Rachmilewitz EA. Oxidative denaturation of red blood cells in thalassemia. Semin Hematol 1990; 27: 70–82.
  • Luetscher JA. Electrophoretic analysis of the proteins of plasma and serous effusions. J Clin Invest 1941; 20: 99–106.
  • Zoellner H, Hou JY, Hochgrebe T et al. Fluorometric and mass spectrometric analysis of nonenzymatic glycosylated albumin. Biochem Biophys Res Commun 2001; 284: 83–89.
  • Hillman RS, Ault KA. Hematology in clinical practice: a guide to diagnosis and management. New York: McGraw-Hill, 1995.
  • McGeary RP, Szyczew AJ, Toth I. Biological properties and therapeutic potential of bilirubin. Mini Rev Med Chem 2003; 3: 253–256.
  • Stocker R. Antioxidant activities of bile pigments. Antioxid Redox Signal 2004; 6: 841–849.
  • Marx JJ, Hider RC. Iron: an essential but potentially harmful nutrient. Eur J Clin Invest 2002; 32 (Suppl 1): 1–2.
  • Hider RC. Nature of nontransferrin-bound iron. Eur J Clin Invest 2002; 32 (Suppl 1): 50–54.
  • Sadrzadeh SM, Graf E, Panter SS, Hallaway PE, Eaton JW. Hemoglobin. A biologic Fenton reagent. J Biol Chem 1984; 259: 14354–14356.
  • Filosa A, Valgimigli L, Pedulli GF et al. Quantitative evaluation of oxidative stress status on peripheral blood in beta-thalassaemic patients by means of electron paramagnetic resonance spectroscopy. Br J Haematol 2005; 131: 135–140.
  • Cighetti G, Duca L, Bortone L et al. Oxidative status and malondialdehyde in beta-thalassaemia patients. Eur J Clin Invest 2002; 32 (Suppl 1): 55–60.
  • Driss F, Vrtovsnik F, Katsahian S et al. Effects of intravenous polymaltose iron on oxidant stress and non-transferrin-bound iron in hemodialysis patients. Nephron 2005; 99: c63–c67.
  • Fang YZ, Yang S, Wu G. Free radicals, antioxidants, and nutrition. Nutrition 2002; 18: 872–879.
  • Mates JM, Perez-Gomez C, Nunez de Castro I. Antioxidant enzymes and human diseases. Clin Biochem 1999; 32: 595–603.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.